Adaptin Bio, Inc. Shareholders' Equity
Adaptin Bio, Inc. (APTN) had Shareholders' Equity of -$1.67 million as of 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-28
- 2026-06-30: Stockholders' Equity Attributable to Parent -$1.67M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$1.78M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.49M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$881.08K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$1.67M S-1 · filed 2026-08-28 | |
| 2026-03-31 | -$1.78M S-1 · filed 2026-08-28 | |
| 2025-12-31 | -$1.49M S-1 · filed 2026-08-28 | |
| 2025-09-30 | -$881.08K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $474.41K S-1 · filed 2026-08-28 | |
| 2025-03-31 | $1.75M S-1 · filed 2026-08-28 | |
| 2024-12-31 | -$4.10M S-1 · filed 2026-08-28 | -$274.06K 10-K · filed 2025-04-15 |
| 2024-09-30 | -$3.24M 10-Q · filed 2025-11-14 | -$235.32K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$2.14M 10-Q · filed 2025-11-14 | -$205.67K 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$1.32M 10-Q · filed 2025-11-14 | -$170.07K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$977.56K S-1 · filed 2026-08-28 | -$112.90K 10-K · filed 2024-04-01 |
| 2023-09-30 | -$78.74K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$35.80K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$31.55K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | -$27.30K 10-K · filed 2025-04-15 | |
| 2022-09-30 | -$23.05K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$18.80K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | -$14.55K 10-Q · filed 2023-11-14 |